European Academy of Dermatology and Venereology (EADV)

September 25–28, 2024
Poster icon

Effect of remibrutinib treatment on disease activity in chronic spontaneous urticaria: Data from the Phase 3 REMIX-1 and REMIX-2 studies

Martin Metz, Sarbjit Saini, Frederic Berard, John Reed, Marcus Maurer, Sabine Altrichter, Chia-Yu Chu, Bharat Suryawanshi, Christine-Elke Ortmann, Nadine Chapman-Rothe, Sibylle Haemmerle, Johannes S. Kern
Novartis logo
© Copyright 2024 Novartis Pharma AG